ACM
VCYT icon

Aster Capital Management’s Veracyte VCYT Stock Holding History

Aster Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27
Closed -$801 – 1268
2026
Q1 		$801 Buy
+27
New +$999 ﹤0.01% 787
2025
Q1 		– Sell
-45
Closed -$1.78K – 1686
2024
Q4 		$1.78K Buy
+45
New +$1.7K ﹤0.01% 979

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Aster Capital Management's VCYT Position: Q2 2026 in Review

Aster Capital Management sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 27 shares — an estimated $801 sold.

Aster Capital Management first reported a position in VCYT in Q4 2024 and held it in 2 quarters. The position peaked at $1.78K in Q4 2024. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Aster Capital Management reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
  • Aster Capital Management sold 27 Veracyte shares in Q2 2026, an estimated $801.
  • Aster Capital Management first reported a position in Veracyte in Q4 2024 and held it in 2 quarters.
  • Aster Capital Management's Veracyte position peaked at $1.78K in Q4 2024.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.